neurocognitive-disorders

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

1. 55/100

   Blood biomarker profiles in young-onset neurocognitive disorders: A cohort study

   ✓ Peer-reviewed alzhub usefulness score 55 out of 100. The Australian and New Zealand journal of psychiatry · 2025-01-17 · Biomarkers

   Discriminating between early-onset Alzheimer's disease, non-Alzheimer's disease neurodegeneration and primary psychiatric disorders causes of young-onset neurocognitive symptoms is possible by combining cognitive profiles with blood biomarkers.

   • Biomarkers
   • Genetics
2. 43/100

   Abundance of Nef and p-Tau217 in Brains of Individuals Diagnosed with HIV-Associated Neurocognitive Disorders Correlate with Disease Severance

   ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Molecular neurobiology · 2021-11-29 · Biomarkers

   HIV-associated neurocognitive disorders (HAND) is a term used to describe a variety of neurological impairments observed in HIV-infected individuals.

   • Biomarkers
3. 52/100

   The reliability and validity of DSM 5 diagnostic criteria for neurocognitive disorder and relationship with plasma neurofilament light in a down syndrome population

   ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Scientific reports · 2021-06-29 · Biomarkers

   The validity of dementia diagnostic criteria depends on their ability to distinguish dementia symptoms from pre-existing cognitive impairments.

   • Biomarkers
   • Diagnosis
   • Down Syndrome
4. 76/100

   Physical exercise and cognitive engagement outcomes for mild neurocognitive disorder: a group-randomized pilot trial

   ✓ Peer-reviewed alzhub usefulness score 76 out of 100. Trials · 2018-10-19 · Cognitive tests and assessment

   Study staff and participants will be kept blind until recruitment is complete for each group.

   • Clinical Trials
   • Brain Scans
   • Lifestyle
5. 43/100

   Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders

   ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Journal of neurovirology · 2015-03-17 · Biomarkers

   HIV-associated neurocognitive disorders (HAND) affect up to 50 % of HIV-infected adults, independently predict HIV morbidity/mortality, and are associated with neuronal damage and monocyte activation.

   • Biomarkers

All topic tags with their study counts